IP Verse

Sanofi Biotechnologies Sas vs. Amgen Inc. - ACT_597355/2023

Explore detailed information on the case number ACT_597355/2023 involving Sanofi Biotechnologies Sas, Regeneron Pharmaceuticals Inc. and Amgen Inc., Amgen Gmbh, Amgen Europe B.V., and others which was filed on 10 Jan, 2024.

Case Details

    Case Number:

    ACT_597355/2023

    Patent Number:

    EP3536712

    Filing Date:

    10 Jan, 2024

    Proceeding Type:

    Proceeding

    Action/Application:

    Infringement Action

    Decision Date:

    13 May, 2025

    Plaintiffs:

    • Sanofi Biotechnologies Sas Represented By Niels Holder
    • Regeneron Pharmaceuticals Inc. Represented By Niels Holder

    Defendants:

    • Amgen Inc. Represented By Johannes Heselberger
    • Amgen Gmbh Represented By Johannes Heselberger
    • Amgen Europe B.V. Represented By Johannes Heselberger
    • Amgen Nv Represented By Johannes Heselberger
    • Amgen S.R.L. Represented By Johannes Heselberger
    • Amgen B.V. Represented By Johannes Heselberger
    • Amgen S.A.S. Represented By Johannes Heselberger

    Judges:

    • Andras Kupecz
    • Berenice Thom
    • Ronny Thomas
    • Xavier DORLAND-GALLIOT

    Court Division:

    First Instance, Local Division - Dusseldorf

Case Decision

May 13, 2025
Document

More cases on EP3536712B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Jul 24, 2025
Case NumberPlaintiffsDefendants
CC_24999/2024Amgen Europe B.V., Amgen Inc., Amgen B.V., Amgen S.R.L., Amgen Nv, Amgen Gmbh, Amgen S.A.S.Regeneron Pharmaceuticals Inc.

More cases on Sanofi Biotechnologies Sas

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Jul 24, 2025
Case NumberPlaintiffsDefendants
APL_572929/2023Sanofi-Aventis Groupe S.A., Regeneron Pharmaceuticals Inc., Sanofi Winthrop Industrie S.A., Sanofi-Aventis Deutschland GmbhAmgen Inc.
CC_586764/2023Regeneron Pharmaceuticals Inc.Amgen Inc.
ACT_10334/2025Regeneron Pharmaceuticals Inc., Sanofi Biotechnology SasAmgen S.R.L., Amgen S.A.S., Amgen Nv, Amgen Gmbh, Amgen Inc., Amgen Europe B.V., Amgen B.V.

More cases on Amgen Inc.

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Jul 24, 2025
Case NumberPlaintiffsDefendants
APL_572929/2023Sanofi-Aventis Groupe S.A., Regeneron Pharmaceuticals Inc., Sanofi Winthrop Industrie S.A., Sanofi-Aventis Deutschland GmbhAmgen Inc.
CC_586764/2023Regeneron Pharmaceuticals Inc.Amgen Inc.
APL_40553/2024Alexion PharmaceuticalsAmgen Technology (Ireland) Unlimited Company, Amgen N.V., Amgen Gmbh, Amgen Ab, Amgen S.A.S., Amgen S.R.L., Amgen Biofarmaceutica Lda., Amgen Zdravila D.O.O.